Aromatase inhibitors and selective estrogen receptor modulators: Unconventional therapies for functional hypogonadism?

Unconventional Therapies ◽

Can biomarkers direct the optimal use of aromatase inhibitors versus selective estrogen receptor modulators?

Nature Clinical Practice Oncology ◽

10.1038/ncponc0444 ◽

2006 ◽

Vol 3 (3) ◽

pp. 134-135

Author(s):

Rachel Schiff ◽

Adrian V Lee

Keyword(s):

Estrogen Receptor ◽

Aromatase Inhibitors ◽

Advances in breast cancer treatment and prevention: preclinical studies on aromatase inhibitors and new selective estrogen receptor modulators (SERMs)

Breast Cancer Research ◽

10.1186/bcr626 ◽

2003 ◽

Vol 5 (5) ◽

Cited By ~ 10

Author(s):

Rachel Schiff ◽

Gary C Chamness ◽

Powel H Brown

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Cancer Treatment ◽

Aromatase Inhibitors ◽

Breast Cancer Treatment ◽

Preclinical Studies ◽

Treatment And Prevention ◽

Role of Aromatase Inhibitors (AIs) and Selective Estrogen Receptor Modulators (SERMs) in the Treatment of Uterine Leiomyoma

Uterine Fibroids ◽

10.1201/9780429155734-13 ◽

2020 ◽

pp. 71-74

Author(s):

Luis S. Noble ◽

Diego Ramirez

Keyword(s):

Estrogen Receptor ◽

Aromatase Inhibitors ◽

Uterine Leiomyoma ◽

Endocrine Therapy with Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors in the Prevention and Adjuvant Therapy Settings

Cancer Treatment and Research - Hormone Receptors in Breast Cancer ◽

10.1007/978-0-387-09463-2_7 ◽

2008 ◽

pp. 1-29

Author(s):

Shelly S. Lo ◽

Kathleen I. Pritchard ◽

Patricia Robinson ◽

Kathy S. Albain

Keyword(s):

Estrogen Receptor ◽

Adjuvant Therapy ◽

Endocrine Therapy ◽

Aromatase Inhibitors ◽

Hormone therapy in breast cancer: Selective estrogen receptor modulators and aromatase inhibitors

PsycEXTRA Dataset ◽

10.1037/e669012010-004 ◽

2009 ◽

Author(s):

Laura Tillman ◽

Shannon Myers

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Hormone Therapy ◽

Aromatase Inhibitors ◽

Safety profiles of aromatase inhibitors and selective estrogen-receptor modulators in the treatment of early breast cancer

International Journal of Clinical Oncology ◽

10.1007/s10147-008-0828-5 ◽

2008 ◽

Vol 13 (5) ◽

pp. 384-394 ◽

Cited By ~ 10

Author(s):

Yutaka Yamamoto ◽

Hirotaka Iwase

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Early Breast Cancer ◽

Aromatase Inhibitors ◽

Relationship Between Breast Density and Selective Estrogen-Receptor Modulators, Aromatase Inhibitors, Physical Activity, and Diet

Integrative Cancer Therapies ◽

10.1177/1534735416628343 ◽

2016 ◽

Vol 15 (2) ◽

pp. 127-144 ◽

Cited By ~ 10

Author(s):

Ernest U. Ekpo ◽

Patrick C. Brennan ◽

Claudia Mello-Thoms ◽

Mark F. McEntee

Keyword(s):

Physical Activity ◽

Estrogen Receptor ◽

Breast Density ◽

Aromatase Inhibitors ◽

Selective Estrogen Receptor Modulators and Aromatase Inhibitors for Breast Cancer Chemoprevention

Current Drug Targets ◽

10.2174/138945011798184164 ◽

2011 ◽

Vol 12 (13) ◽

pp. 1874-1887 ◽

Cited By ~ 12

Author(s):

Victor G. Vogel

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Aromatase Inhibitors ◽

Cancer Chemoprevention ◽

Breast Cancer Chemoprevention ◽

Ovulation induction is not the same as superovulation: the effect of selective estrogen receptor modulators and aromatase inhibitors

Fertility and Sterility ◽

10.1016/j.fertnstert.2003.06.002 ◽

2003 ◽

Vol 80 (6) ◽

pp. 1333-1334 ◽

Cited By ~ 1

Author(s):

David E Tourgeman

Keyword(s):

Estrogen Receptor ◽

Aromatase Inhibitors ◽

Ovulation Induction ◽

Tamoxifen (Selective Estrogen-Receptor Modulators) and Aromatase Inhibitors as Potential Perioperative Thrombotic Risk Factors in Free Flap Breast Reconstruction

Plastic & Reconstructive Surgery ◽

10.1097/prs.0000000000001127 ◽

2015 ◽

Vol 135 (4) ◽

pp. 670e-679e ◽

Cited By ~ 19

Author(s):

Michael N. Mirzabeigi ◽

Jonas A. Nelson ◽

John P. Fischer ◽

Steven J. Kovach ◽

Joseph M. Serletti ◽

...

Keyword(s):

Risk Factors ◽

Estrogen Receptor ◽

Breast Reconstruction ◽

Aromatase Inhibitors ◽

Free Flap ◽

Thrombotic Risk ◽